Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 286 AL 300

Donanemab: Not two without a third

Kurkinen M.

Adv Clin Exp Med. 2023 Oct;32(10):1085-1087. doi: 10.17219/acem/172673.

Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus

Veselov IM, Vinogradova DV, Maltsev AV, Shevtsov PN, Spirkova EA, Bachurin SO, Shevtsova EF.

Int J Mol Sci. 2023 Sep 22;24(19):14450. doi: 10.3390/ijms241914450.

Anti-Amyloid Therapies for Alzheimer's Disease and the Amyloid Cascade Hypothesis

Fedele E.

Int J Mol Sci. 2023 Sep 24;24(19):14499. doi: 10.3390/ijms241914499.

Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges

He C, Gu J, Wang D, Wang K, Wang Y, You Q, Wang L.

Eur J Med Chem. 2023 Dec 5;261:115859. doi: 10.1016/j.ejmech.2023.115859. Epub 2023 Oct 6.

Landscape of Phase II Trials in Alzheimer's Disease

Lee A, Shan D, Castle D, Rajji TK, Ma C.

J Alzheimers Dis. 2023;96(2):745-757. doi: 10.3233/JAD-230660.

Understanding Alzheimer's Disease and its Metal Chelation Therapeutics: A Narrative Review

Thakur R, Karwasra R, Umar T.

Curr Pharm Des. 2023;29(30):2377-2386. doi: 10.2174/0113816128263992231012113847.

Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus

Fauzi A, Thoe ES, Quan TY, Yin ACY.

J Diabetes Complications. 2023 Nov;37(11):108629. doi: 10.1016/j.jdiacomp.2023.108629. Epub 2023 Oct 18.

The location, physiology, pathology of hippocampus Melatonin MT(2) receptor and MT(2)-selective modulators

Feng Y, Jiang X, Liu W, Lu H.

Eur J Med Chem. 2023 Dec 15;262:115888. doi: 10.1016/j.ejmech.2023.115888. Epub 2023 Oct 17.

Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches

Gholami A.

Neurosci Lett. 2023 Nov 20;817:137532. doi: 10.1016/j.neulet.2023.137532. Epub 2023 Oct 20.

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial

Delrieu J, Vellas B, Guyonnet S, Cantet C, Ovod V, Li Y, Bollinger J, Bateman R, Andrieu S; MAPT/DSA group.

Alzheimers Res Ther. 2023 Oct 23;15(1):183. doi: 10.1186/s13195-023-01325-3.

Editorial: The State of Alzheimer's Research and the Path Forward

Fillit HM, Vellas B, Hara Y.

J Prev Alzheimers Dis. 2023;10(4):617-619. doi: 10.14283/jpad.2023.102.

Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics

Riessland M, Orr ME.

J Prev Alzheimers Dis. 2023;10(4):633-646. doi: 10.14283/jpad.2023.104.

Modulation of Mitochondrial Function as a Therapeutic Strategy for Neurodegenerative Diseases

Trushina E, Nguyen TKO, Trushin S.

J Prev Alzheimers Dis. 2023;10(4):675-685. doi: 10.14283/jpad.2023.108.

Targeting Endogenous Mechanisms of Brain Resilience for the Treatment and Prevention of Alzheimer's Disease

Shanks HRC, Onuska KM, Massa SM, Schmitz TW, Longo FM.

J Prev Alzheimers Dis. 2023;10(4):699-705. doi: 10.14283/jpad.2023.110.

Metformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias

Tahmi M, Luchsinger JA.

J Prev Alzheimers Dis. 2023;10(4):706-717. doi: 10.14283/jpad.2023.113.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias